Topic: Precision Oncology: Unleashing the Potential of Tumor-Selective Drug Strategies

Precision oncology has revolutionized cancer treatment by tailoring therapies to the genetic and molecular characteristics of individual tumors. This Special Issue delves into the exciting realm of tumor-selective drug strategies, where the potential to optimize therapeutic outcomes and minimize side effects is at the forefront. Our collection of articles aims to explore the latest advancements, challenges, and future prospects in precision oncology, shedding light on novel approaches that promise to reshape the landscape of cancer treatment.

Potential Topics:
1. Genomic Profiling in Precision Oncology: An in-depth examination of genomic profiling techniques and their role in identifying targetable mutations in cancer;
2. Targeted Therapies and Personalized Medicine: Exploring the development and clinical applications of tumor-specific drugs and personalized treatment regimens;
3. Immunotherapy and Tumor Microenvironment: Investigating the intersection of precision oncology and immunotherapy, focusing on strategies to harness the immune system against cancer;
4. Liquid Biopsies in Early Detection: An exploration of liquid biopsy technologies and their potential for early cancer detection and monitoring treatment responses;
5. Emerging Biomarkers for Treatment Selection: Highlighting the latest biomarkers and their significance in guiding treatment decisions in precision oncology;
6. Challenges in Drug Resistance: Discussing the mechanisms of drug resistance in targeted therapies and strategies to overcome them;
7. Clinical Trials and Patient Stratification: Examining the design of clinical trials that incorporate precision oncology approaches and patient stratification;
8. Ethical and Regulatory Considerations: An overview of ethical dilemmas and regulatory challenges associated with implementing precision oncology in clinical practice.

20 Aug 2024